Jhanelle Gray, M.D.

Paclitaxel

2 trials

phase_1phase_2

Phase I - GM.CD40L.CCL21 Vaccinations

phase_1_2

MEK162

phase_1

Nivolumab

phase_1_2

Vorinostat

phase_1_2

AZD1775

phase_2

Panobinostat (LBH589)

phase_1

Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC

+7 more interventions

15 unique interventions3 categories

Analytics

Trial Phases

Phase 16

Phase 24

Trial Status

Completed5

Other2

Role Distribution

Principal Investigator7

PI Rate100%

Activity Timeline

Clinical Trials (7)

NCT03177291Phase 1Completed

Advanced CancerLung CancerMetastatic Lung Cancer+3 more

PrincipalinvestigatorStart date: 2017-09-26

NCT02638090Phase 1/2Active Not Recruiting

Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC)

Lung CancerNon-small Cell Lung Cancer

PrincipalinvestigatorStart date: 2016-03-22

NCT02513563Phase 2Completed

AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung Cancer

Lung Cancer

PrincipalinvestigatorStart date: 2015-10-13

NCT01859026Phase 1Completed

A Phase I/IB Trial of MEK162 in Combination With Erlotinib in NSCLC Harboring KRAS or EGFR Mutation

Lung CancerNon-Small Cell Lung Cancer

PrincipalinvestigatorStart date: 2013-12-30

NCT01433172Phase 1/2Completed

Combination Immunotherapy of GM.CD40L Vaccine With CCL21 in Lung Cancer

AdenocarcinomaLung Cancer

PrincipalinvestigatorStart date: 2012-03-26

NCT00738751Phase 1Completed

Phase I Study of LBH589 & Erlotinib for Advanced Aerodigestive Tract Cancers

Head and Neck CancerLung Cancer

Principalinvestigator

NCT02466568Phase 1/2Withdrawn

Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the Lung

Adenocarcinoma of the LungLung Cancer

Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Lung Cancer7 Carcinoma, Non-Small-Cell Lung3 Adenocarcinoma1 Adenocarcinoma of the Lung1 Advanced Cancer1 Cancer of Head and Neck1 Metastatic Lung Cancer1 Non-Squamous Non-Small Cell Neoplasm of Lung1

Affiliations

H. Lee Moffitt Cancer Center and Research Institute

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

32 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungLung CancerAdenocarcinoma

Lung CancerAdenocarcinomaCarcinoma, Non-Small-Cell Lung

James L Gulley, M.D.

National Cancer Institute (NCI)

18 trials

Shared therapeutic areas:

Lung CancerCarcinoma, Non-Small-Cell LungCancer of Head and Neck

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

21 trials

Shared therapeutic areas:

Cancer of Head and NeckLung CancerCarcinoma, Non-Small-Cell Lung

Michael B Gill

Power Life Sciences Inc.

105 trials

Shared therapeutic areas:

Lung CancerCarcinoma, Non-Small-Cell Lung

Dong-Xin Wang, MD, PhD

Peking University First Hospital

74 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungLung Cancer

You Lu, MD

West China Hospital

18 trials

Shared therapeutic areas:

Lung CancerCancer of Head and Neck

John D. Hainsworth, MD

SCRI Development Innovations, LLC

26 trials

Shared therapeutic areas:

Worked with same sponsors:

Genentech, Inc.Novartis

Lung CancerCancer of Head and Neck

Aminah Jatoi, MD

Mayo Clinic

29 trials

Shared therapeutic areas:

Advanced CancerLung Cancer

Lin Shen, MD

Peking University Cancer Hospital & Institute

20 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungLung Cancer

Yongchang Zhang, MD

Hunan Cancer Hospital

27 trials

Shared therapeutic areas: